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The mechanism of molecular oxygen entry into the buried active site of the
copper amine oxidase family has been investigated in several family members
using biochemical, structural and in silico methods. These studies have revealed
a structurally conserved  -sandwich which acts as a hydrophobic reservoir from
which molecular oxygen can take several species-speciﬁc preferred pathways to
the active site. Escherichia coli copper amine oxidase (ECAO) possesses an
extra N-terminal domain that lies close to one entrance to the  -sandwich. In
order to investigate whether the presence of this domain alters molecular
oxygen entry in this enzyme, xenon was used as a molecular oxygen binding-site
probe. The resulting 2.5 A ˚ resolution X-ray crystal structure reveals xenon
bound in similar positions to those observed in xenon-derivative crystal
structures of other family members, suggesting that the N-terminal domain does
not affect oxygen entry and that the E. coli enzyme takes up oxygen in a similar
manner to the rest of the copper amine oxidase family.
1. Introduction
Copper amine oxidases (CuAOs) catalyse the oxidation of a wide
range of amine substrates to generate a product aldehyde, ammonia
and hydrogen peroxide (Mure et al., 2002). They are ubiquitous in
nature and in humans are involved in diverse processes including cell
adhesion and signalling (Salmi et al., 1998; Elmore et al., 2002; Yu et
al., 2003). In bacteria, they play a role in general nitrogen catabolism
(Parrott et al., 1987; Hacisalihoglu et al., 1997). They contain a
protein-derived cofactor that is generated autocatalytically by post-
translation modiﬁcation of a conserved endogenous tyrosine to
generate 2,4,5-trihydroxylphenylalanine quinone (TPQ), requiring
only the presence of copper and molecular oxygen (Cai & Klinman,
1994; Kim et al., 2002). TPQ is situated in the core of the protein at
the end of a well deﬁned substrate-access channel next to a type II
copper coordinated by three histidines (Fig. 1; Parsons et al., 1995;
Duff et al., 2006; Wilce et al., 1997; Lunelli et al., 2005; Kumar et al.,
1996; Airenne et al., 2005; Li et al., 1998). The Escherichia coli enzyme
(ECAO) shows a preference for small aromatic amine substrates such
as phenethylamine and tyramine (Roh et al., 1994). The catalytic
reaction proceeds via two half-reactions; the aldehyde product is
released at the end of the reductive half-reaction before reduction of
molecular oxygen in the oxidative half-reaction (Fig. 2).
Extensive structural and biochemical analyses of CuAOs from
prokaryotic and eukaryotic sources have revealed that molecular
oxygen binds on the opposite side of TPQ to the amine substrate
(Fig. 2). There has been considerable interest in dissecting the
pathway by which oxygen reaches and binds in the active site.
Structural and mutagenesis studies have shown that oxygen does not
enter via the substrate channel and that other possibly speciﬁc
oxygen-access pathways must be present (Wilce et al., 1997; Li et al.,
1998; Johnson et al., 2007; Wilmot et al., 1999; Goto & Klinman, 2002).
Several recent crystallographic studies of oxygen entry have been
carried out using xenon as a probe to identify possible molecular
oxygen-binding sites that may be part of the putative oxygen-entry
pathway (Lunelli et al., 2005; Johnson et al., 2007; Duff et al., 2004).Xenon-complex crystal structures are now available for the CuAOs
from Hansenula polymorpha (HPAO), Pisum sativum (PSAO),
bovine serum (BSAO), Pichia pastoris (PPLO) and Arthobacter
globiformis (AGAO) (Lunelli et al., 2005; Johnson et al., 2007; Duff et
al., 2004). These structures have revealed a consistent pattern of
xenon binding that has implicated a major pathway for oxygen entry
through a conserved  -sandwich (Fig. 3). Very recently, in silico
experiments that calculated likely low-energy pathways for oxygen
entry in HPAO, PSAO, AGAO and PPLO were carried out that
supported the major pathway identiﬁed by the structural studies
(Johnson et al., 2007).
ECAO is distinct from Gram positive bacterial and yeast CuAOs in
that it possesses an extra 9.3 kDa N-terminal domain, which gives
ECAO a characteristic ‘mushroom stalk and cap’ shape (Parsons et
al., 1995). Mammalian CuAOs also possess an N-terminal domain
that is thought to act as a membrane anchor (Smith et al., 1998) but
has not yet been visualized crystallographically (Airenne et al., 2005).
Biochemical and structural characterization of ECAO indicate that
the binding of oxygen in the active site is similar to that of the other
family members (Smith & McPherson, 2008); however, it is possible
that the presence of the additional N-terminal domain, which is
located at one end of the structurally conserved  -sandwich, could
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Figure 2
Schematic catalytic cycle of CuAOs identifying the key intermediates in the reaction pathway. Shown are the type-2 copper centre, the protein-derived cofactor TPQ and the
off-metal O2-binding site located in the vicinity of a conserved active-site methionine (Met699 in ECAO). I is the resting state of the enzyme, intermediate II is the product
Schiff base, intermediate III is the reduced TPQ or aminoquinol form, intermediate IV shows the proposed off-metal-bound dioxygen species prior to oxygen activation and
reduction and intermediate V is the iminoquinone species which hydrolyses to release ammonia, completing the catalytic cycle.
Figure 1
The structure of ECAO (PDB code 1dyu) showing the substrate-entrance channel
(magenta surface) and active site (Murray et al., 1999). The lower right panel is a
more detailed view of the active site showing the TPQ, copper(II) ion, three
coordinating histidine residues (sticks coloured by atom type) and the end of the
substrate-entrance channel (magenta surface). The substrate-entrance channel was
calculated using CAVER (Petrek et al., 2006) and the image was prepared using
PyMOL (DeLano, 2002).alter or provide an alternate pathway for oxygen entry. In order to
investigate this possibility, we have determined the crystal structure
of ECAO in complex with xenon at 2.5 A ˚ resolution.
2. Experimental
2.1. ECAO expression, purification and crystallization
ECAO expression and puriﬁcation was carried out as previously
described (Murray et al., 1999). ECAO was concentrated to 8 mg ml
 1
and crystals were grown by vapour diffusion at 291 K. Large pink-
coloured crystals grew over two weeks in 100 mM HEPES pH 7 and
1.2 M sodium citrate.
2.2. Xenon derivatization
ECAO crystals were harvested and transferred into a cryoprotec-
tant solution comprising crystal-growth mother liquor containing
20% glycerol before being exposed to xenon for 8 min at 2.5 MPa in
an Oxford Cryosystems Xcell. After derivatization, crystals were
immediately ﬂash-cooled in liquid nitrogen for X-ray data collection.
2.3. X-ray data collection and processing
A 2.5 A ˚ diffraction data set was collected on beamline 14.1 at the
SRS, Daresbury. Data collection was carried out at the highest
beamline-accessible wavelength of 1.48 A ˚ to maximize the anom-
alous signal from xenon (Xe f00 = 6.9) and data were recorded using a
Quantum4 ADSC CCD detector. The crystal was maintained at
100 K using a Cryostream (Oxford Cryosystems). 360  of data were
collected with an oscillation angle of 1  and an exposure time of 30 s.
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Figure 4
(a) ECAO monomer showing the substrate-entry channel as a magenta surface and
the putative oxygen-entry pathway as a green surface (generated by placing dummy
atoms along the channel). The Xe sites observed in ECAO are shown as magenta
spheres. TPQ and copper ligands are shown as sticks coloured by element and
copper is shown as a bronze sphere. (b) ECAO active site, coloured as before,
showing xenons 1/2, 4/11, 7/5, 8/– and 9/–. This image was generated using PyMOL
(DeLano, 2002).
Figure 3
ECAO subunit showing the substrate-entry channel as a magenta surface and the
putative oxygen-entry pathway as a green surface (generated by placing dummy
atoms along the channel). The xenon sites observed in PPLO, HPAO, AGAO and
PSAO are shown as cyan spheres. TPQ and copper ligands are shown as sticks
coloured by element and copper is shown as a bronze sphere. This image was
generated using PyMOL (DeLano, 2002).
Table 1
Data collection and processing.
Values in parentheses are for the highest resolution shell.
Wavelength (A ˚ ) 1.48
Temperature (K) 100
Unit-cell parameters (A ˚ ) a = 166.9, b = 134.6, c = 80.3
Space group P212121
Resolution (A ˚ ) 50.0–2.5 (2.55–2.50)
Rmerge† (%) 12.3 (44.8)
Completeness (%) 98.6 (94.9)
Redundancy 10.1 (7.4)
Mean I/ (I) 23.6 (4.4)
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the observed
intensity and hI(hkl)i is the average intensity for multiple measurements.The diffraction data were processed using MOSFLM and scaled using
SCALA (Leslie, 1992; Evans, 1993; Table 1).
2.4. Refinement and model building
All reﬁnement and model building was carried out using the CCP4
software suite and Coot (Collaborative Computational Project,
Number 4, 1994; Emsley & Cowtan, 2004). Initial maps were calcu-
lated by direct Fourier transform using the structure of native ECAO
(PDB code 1dyu; Murray et al., 1999). An anomalous difference map
was calculated and examined to locate possible xenon sites. 50 peaks
were identiﬁed in the map with a   level of 4 or above. Two of these
(8.5 and 8.0 r.m.s.) were located at sites known to bind calcium in the
native enzyme (Ca f00 = 1.2 at 1.48 A ˚ ). Weaker peaks (3.6–4.6 r.m.s.)
were located at the copper site and on S atoms, which is expected at
this wavelength (Cu f00 = 0.55 at 1.48 A ˚ ,Sf00 = 0.5 at 1.48 A ˚ ). The
remaining peaks were assigned as xenon when they were higher than
4 r.m.s., did not overlap with copper, calcium or sulfur, corresponded
to positive electron density in the Fo   Fc electron-density map and
were located in mainly hydrophobic pockets. The occupancy of each
xenon was modiﬁed such that after restrained reﬁnement there was
no further positive electron density in the Fo   Fc map and the B
factors were similar to those of nearby atoms. The structure was
further reﬁned using iterative cycles of model building and restrained
reﬁnementtoaﬁnalRfactorof16.1%andanRfreeof21.9%(Table2).
Structure validation was carried out using SFCHECK and PRO-
CHECK (Laskowski et al., 1993; Vaguine et al., 1999).
3. Results and discussion
After reﬁnement, 11 xenon-binding sites were found in the structure
(Fig. 4a). Although the occupancy of all sites was low (0.1–0.45), this
is consistent with the xenon occupancies observed in other CuAO
xenon complexes (Lunelli et al., 2005; Johnson et al., 2007; Duff et al.,
2004). Xenons were numbered according to their occupancy (from
high to low occupancy). The Xe atoms were bound in hydrophobic
pockets located in either theamine substrate-entry channel or around
the conserved  -sandwich oxygen-entry pathway (Table 3). Nearly
identical sites were observed in both subunits of ECAO present in the
asymmetric unit
1.
Two Xe atoms are bound in the amine substrate-entry channel.
Xenon 4/11 occupies a site between Tyr381 and Tyr387 that is
equivalent to that previously observed in AGAO and HPAO. Tyr381
is proposed to act as a gate regulating substrate access to the TPQ
and the aromatic rings of Tyr381 and Tyr387 allow stacking inter-
actions with the aromatic moiety of aromatic amine substrates
(Wilmot et al., 1997, 2004). Xenon 1/2 is bound further from the active
site but is still close to the amine-substrate channel (Fig. 4b).
Two xenons, xenon 7/5 and xenon 9/– (only in monomer A), are
bound inside the ‘top’ entrance of the  -sandwich, close to the xenon-
binding sites observed in PPLO and PSAO (Duff et al., 2004; Figs. 4a
and 4b). We did not observe any xenon-binding sites inside the lower
half of the  -sandwich near the ‘bottom’ entrance to the putative
oxygen-entry pathway. However, two xenon-binding sites (3/6 and
8/–) ﬂank the lower half of the  -sandwich, binding on its external
face (Fig. 4a). This is consistent with the other copper amine oxidase–
xenon complexes, in which a xenon-binding site within the bottom
half of the  -sandwich channel has only been reported for AGAO
(Fig. 3). The lack of xenon-binding sites in this region in PPLO, PSAO
and HPAO suggests that xenon binding is not as favourable in this
region of the  -sandwich regardless of the presence or absence of an
N-terminal domain. A ﬁnal xenon, xenon –/10, is bound at the edge of
ECAO in a hydrophobic pocket and is not close to any previously
observed xenon position.
The xenon-complex ECAO structure reported here shows that
molecular oxygen is likely to access the ECAO active site by very
similar pathways to those proposed by experimental and in silico
studies in other CuAOs (Lunelli et al., 2005; Johnson et al., 2007; Duff
et al., 2004). No xenon-binding sites are observed in the ECAO
N-terminal domain itself nor does the presence of this domain appear
to affect xenon binding in the lower half of the  -sandwich when
compared with other CuAOs for which xenon complexes have been
determined. These observations indicate that the N-terminal domain
does not play a role in oxygen entry during ECAO catalysis, which is
consistent with the lack of conservation of the N-terminal domain
across the CuAOs.
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Table 2
Structure reﬁnement and validation.
Values in parentheses are for the highest resolution shell.
Rwork† 16.1 (21.9)
Rfree‡ 21.9 (30.1)
Total No. of reﬂections 64552
No. of reﬂections in the Rwork set 61345 (3900)
No. of reﬂections in the Rfree set 3207 (220)
No. of non-H atoms 11947
No. of protein atoms 11348
No. of ligand atoms 17
No. of solvent atoms 582
R.m.s.d. from ideality
Bonds (A ˚ ) 0.017
Angles ( )1 . 7
Average B factors (A ˚ 2)
Main chain 39.6
Side chain 41.5
Ligands 49.4
Solvent 44.7
Ramachandran plot
Allowed regions (%) 99.8
Disallowed regions (%) 0.2
PDB code 2w0q
† R factor =
P   jFoj j Fcj
   =
P
jFoj, where |Fo| is the observed structure-factor
amplitude and |Fo| is the calculated structure-factor amplitude. ‡ Rfree is the R factor
based on 5% of the data excluded from reﬁnement.
Table 3
Xenon sites.
Xenon
site
Peak
height
Occupancy/
B factor (A ˚ 2) Surrounding residues
1 13 0.45/58 Subunit A Leu189, Phe192, Phe387, Leu392
2 9.9 0.30/48 Subunit B Leu189, Phe192, Tyr387, Leu392
3 9.9 0.30/39 Subunit A His94, Ala140, Met322, Thr344
4 6.5 0.35/57 Subunit A Phe192, Pro224, Leu225, Tyr381, Tyr387
5 5.8 0.15/48 Subunit B Leu543, Ile570, Gln578, Leu638
6 5.7 0.3/57 Subunit B His94, Ala140, Met322, Thr344
7 5.6 0.2/46 Subunit A Leu543, Ile570, Gln578, Leu638
8 4.9 0.15/27 Subunit A Ile396, Ile460
9 4.5 0.1/37 Subunit A Leu543, Leu588, Ile605, Leu638, Val681
10 4.5 0.15/47 Subunit B Pro458, Met563, Gln620
11 4.2 0.2/58 Subunit B Phe192, Pro224, Leu225, Tyr381, Tyr387
1 As ECAO is a dimer in the asymmetric unit some xenon sites are observed in
equivalent positions in both monomers, while others are observed in only one
of the subunits. In the following discussion of individual xenon sites, those
observed in both monomers are identiﬁed as ‘xenon A/B’, where A is the
xenon number in monomer A and B that in monomer B. When a xenon is
observed in only a single subunit, this is indicated as either ‘xenon A/–’ or
‘xenon –/B’.PP is the recipient of a Wellcome Trust Studentship. This work was
also supported by the Biotechnology and Biological Sciences
Research Council (Grant No. BB/C00468X/1) and the RCUK(ARP).
We thank Dr Thomas Edwards, Dr Chi Trinh and the beamline 14.1
local contacts for assistance during data collection.
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